Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO

Javier Villanueva-Meyer, D. Thompson, I. Mena, C. S. Marcus

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We calculated lacrimal gland dosimetry for the brain imaging agent 99mTc-HMPAO. One hundred thirty-eight patients were studied using a dedicated brain imaging device. Only 11% of the patients showed lacrimal gland uptake. For a 740-MBq (20 mCi) injected dose of 99mTc-HMPAO, the radiation exposure to the lacrimal glands is 10.2 mGy (1.02 rad), or 0.0138 mGy/MBq (0.051 rad/mCi). These values are five times lower than the ones reported by the manufacturer of HMPAO. As the dosimetry calculation is only for subjects showing 99mTc-HMPAO uptake in the lacrimal gland, the average radiation dose to all subjects is considerably lower, 1/10 of the estimated value.

Original languageEnglish (US)
Pages (from-to)1237-1239
Number of pages3
JournalJournal of Nuclear Medicine
Volume31
Issue number7
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Lacrimal Apparatus
Technetium
Technetium Tc 99m Exametazime
Neuroimaging
Radiation
Equipment and Supplies

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Villanueva-Meyer, J., Thompson, D., Mena, I., & Marcus, C. S. (1990). Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. Journal of Nuclear Medicine, 31(7), 1237-1239.

Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. / Villanueva-Meyer, Javier; Thompson, D.; Mena, I.; Marcus, C. S.

In: Journal of Nuclear Medicine, Vol. 31, No. 7, 01.01.1990, p. 1237-1239.

Research output: Contribution to journalArticle

Villanueva-Meyer, J, Thompson, D, Mena, I & Marcus, CS 1990, 'Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO', Journal of Nuclear Medicine, vol. 31, no. 7, pp. 1237-1239.
Villanueva-Meyer J, Thompson D, Mena I, Marcus CS. Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. Journal of Nuclear Medicine. 1990 Jan 1;31(7):1237-1239.
Villanueva-Meyer, Javier ; Thompson, D. ; Mena, I. ; Marcus, C. S. / Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO. In: Journal of Nuclear Medicine. 1990 ; Vol. 31, No. 7. pp. 1237-1239.
@article{c374a5e9cc86480e9922a5567e87c907,
title = "Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO",
abstract = "We calculated lacrimal gland dosimetry for the brain imaging agent 99mTc-HMPAO. One hundred thirty-eight patients were studied using a dedicated brain imaging device. Only 11{\%} of the patients showed lacrimal gland uptake. For a 740-MBq (20 mCi) injected dose of 99mTc-HMPAO, the radiation exposure to the lacrimal glands is 10.2 mGy (1.02 rad), or 0.0138 mGy/MBq (0.051 rad/mCi). These values are five times lower than the ones reported by the manufacturer of HMPAO. As the dosimetry calculation is only for subjects showing 99mTc-HMPAO uptake in the lacrimal gland, the average radiation dose to all subjects is considerably lower, 1/10 of the estimated value.",
author = "Javier Villanueva-Meyer and D. Thompson and I. Mena and Marcus, {C. S.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "31",
pages = "1237--1239",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO

AU - Villanueva-Meyer, Javier

AU - Thompson, D.

AU - Mena, I.

AU - Marcus, C. S.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We calculated lacrimal gland dosimetry for the brain imaging agent 99mTc-HMPAO. One hundred thirty-eight patients were studied using a dedicated brain imaging device. Only 11% of the patients showed lacrimal gland uptake. For a 740-MBq (20 mCi) injected dose of 99mTc-HMPAO, the radiation exposure to the lacrimal glands is 10.2 mGy (1.02 rad), or 0.0138 mGy/MBq (0.051 rad/mCi). These values are five times lower than the ones reported by the manufacturer of HMPAO. As the dosimetry calculation is only for subjects showing 99mTc-HMPAO uptake in the lacrimal gland, the average radiation dose to all subjects is considerably lower, 1/10 of the estimated value.

AB - We calculated lacrimal gland dosimetry for the brain imaging agent 99mTc-HMPAO. One hundred thirty-eight patients were studied using a dedicated brain imaging device. Only 11% of the patients showed lacrimal gland uptake. For a 740-MBq (20 mCi) injected dose of 99mTc-HMPAO, the radiation exposure to the lacrimal glands is 10.2 mGy (1.02 rad), or 0.0138 mGy/MBq (0.051 rad/mCi). These values are five times lower than the ones reported by the manufacturer of HMPAO. As the dosimetry calculation is only for subjects showing 99mTc-HMPAO uptake in the lacrimal gland, the average radiation dose to all subjects is considerably lower, 1/10 of the estimated value.

UR - http://www.scopus.com/inward/record.url?scp=0025372312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025372312&partnerID=8YFLogxK

M3 - Article

C2 - 2362204

AN - SCOPUS:0025372312

VL - 31

SP - 1237

EP - 1239

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -